Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pedro Ramos

Showing results (171-180 of 192) with videos related to

Pageof 20
Sort By:
JCO Global Oncology|May 22, 2023
Clinical Outcomes and Prognostic Factors of Patients With Early Malignant Melanoma in One Latin American Country: Results of the Epidemiological Registry of Malignant Melanoma in Colombia StudyAylen Vanessa Ospina Serrano, Fernando Contreras, Iván Triana, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|March 14, 2023
Therapeutic effect of <b>α</b>7 nicotinic receptor activation after ischemic stroke in ratsLaura Aguado, Ana Joya, Maider Garbizu, et al.
Nature Communications|May 2, 2019
Development and application of a high-content virion display human GPCR arrayGuan-Da Syu, Shih-Chin Wang, Guangzhong Ma, et al.
Cancers|June 26, 2025
Functional and Oncologic Outcomes in Single-Kidney Patients Treated with Robot-Assisted Partial Nephrectomy for Renal Tumors: Results from a Prospectively Maintained Dataset of a Single Tertiary Referral CenterAntonio Andrea Grosso, Luca Lambertini, Fabrizio Di Maida, et al.
Blood|February 15, 2007
Ineffective erythropoiesis in beta-thalassemia is characterized by increased iron absorption mediated by down-regulation of hepcidin and up-regulation of ferroportinSara Gardenghi, Maria F Marongiu, Pedro Ramos, et al.
The Journal of Clinical Investigation|November 25, 2010
Hepcidin as a therapeutic tool to limit iron overload and improve anemia in β-thalassemic miceSara Gardenghi, Pedro Ramos, Maria Franca Marongiu, et al.
Nature Nanotechnology|January 15, 2024
Urease-powered nanobots for radionuclide bladder cancer therapyCristina Simó, Meritxell Serra-Casablancas, Ana C Hortelao, et al.
Theranostics|May 17, 2021
Longitudinal evaluation of a novel BChE PET tracer as an early <i>in vivo</i> biomarker in the brain of a mouse model for Alzheimer diseaseLuka Rejc, Vanessa Gómez-Vallejo, Ana Joya, et al.
American Journal of Clinical Oncology|October 22, 2014
The Frequency and Type of K-RAS Mutations in Mexican Patients With Colorectal Cancer: A National StudySusana G Cárdenas-Ramos, Gregorio Alcázar-González, Luisa M Reyes-Cortés, et al.
Advanced Healthcare Materials|May 20, 2026
Pulmonary Surfactant Nanoparticles for Lung-Targeted and Dose-Efficient DeliveryLaura Fernández-Méndez, Marina Piñol-Cancer, Itziar Souto-Riobó, et al.
Pageof 20

Showing results (171-180 of 192) with videos related to

Sort By:
Pageof 20
JCO Global Oncology|May 22, 2023
Clinical Outcomes and Prognostic Factors of Patients With Early Malignant Melanoma in One Latin American Country: Results of the Epidemiological Registry of Malignant Melanoma in Colombia StudyAylen Vanessa Ospina Serrano, Fernando Contreras, Iván Triana, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|March 14, 2023
Therapeutic effect of <b>α</b>7 nicotinic receptor activation after ischemic stroke in ratsLaura Aguado, Ana Joya, Maider Garbizu, et al.
Nature Communications|May 2, 2019
Development and application of a high-content virion display human GPCR arrayGuan-Da Syu, Shih-Chin Wang, Guangzhong Ma, et al.
Cancers|June 26, 2025
Functional and Oncologic Outcomes in Single-Kidney Patients Treated with Robot-Assisted Partial Nephrectomy for Renal Tumors: Results from a Prospectively Maintained Dataset of a Single Tertiary Referral CenterAntonio Andrea Grosso, Luca Lambertini, Fabrizio Di Maida, et al.
Blood|February 15, 2007
Ineffective erythropoiesis in beta-thalassemia is characterized by increased iron absorption mediated by down-regulation of hepcidin and up-regulation of ferroportinSara Gardenghi, Maria F Marongiu, Pedro Ramos, et al.
The Journal of Clinical Investigation|November 25, 2010
Hepcidin as a therapeutic tool to limit iron overload and improve anemia in β-thalassemic miceSara Gardenghi, Pedro Ramos, Maria Franca Marongiu, et al.
Nature Nanotechnology|January 15, 2024
Urease-powered nanobots for radionuclide bladder cancer therapyCristina Simó, Meritxell Serra-Casablancas, Ana C Hortelao, et al.
Theranostics|May 17, 2021
Longitudinal evaluation of a novel BChE PET tracer as an early <i>in vivo</i> biomarker in the brain of a mouse model for Alzheimer diseaseLuka Rejc, Vanessa Gómez-Vallejo, Ana Joya, et al.
American Journal of Clinical Oncology|October 22, 2014
The Frequency and Type of K-RAS Mutations in Mexican Patients With Colorectal Cancer: A National StudySusana G Cárdenas-Ramos, Gregorio Alcázar-González, Luisa M Reyes-Cortés, et al.
Advanced Healthcare Materials|May 20, 2026
Pulmonary Surfactant Nanoparticles for Lung-Targeted and Dose-Efficient DeliveryLaura Fernández-Méndez, Marina Piñol-Cancer, Itziar Souto-Riobó, et al.
Pageof 20